𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration

✍ Scribed by Nadia Stefanova; Monika Mitschnigg; Imad Ghorayeb; Elsa Diguet; Felix Geser; Francois Tison; Werner Poewe; Gregor K. Wenning

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
476 KB
Volume
78
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Previous studies in rodent models of neurodegenerative disorders have demonstrated that minocycline exerts neuroprotective effects unrelated to its antimicrobial action. The purpose of the present study was to analyze whether minocycline exhibits neuroprotective activity in a rat model of striatonigral degeneration (SND), the core pathology underlying levodopa‐unresponsive parkinsonism associated with multiple system atrophy (MSA). We observed no significant effect of minocycline on locomotor impairment in double‐lesioned SND rats. Minocycline significantly suppressed astroglial and microglial activation (P < 0.01); however, 3′5′‐monophosphate‐regulated phosphoprotein (DARPP 32) immunohistochemistry revealed no significant differences in striatal lesion volume of minocycline‐treated versus untreated control SND rats. Furthermore, there was no protection of nigral dopaminergic neurons in the double‐lesion model. We conclude that despite its astrocytic and microglial suppression, minocycline failed to attenuate lesion‐induced neuronal damage in the SND rat model. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Angiotensin-converting enzyme inhibition
Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism
✍ A. Lopez-Real; P. Rey; R. Soto-Otero; E. Mendez-Alvarez; J.L. Labandeira-Garcia 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 1 views

## Abstract It is now established that the brain possesses a local renin‐angiotensin system and that angiotensin II exerts multiple actions in the nervous system, including regulation of striatal dopamine release. Furthermore, angiotensin activates NADPH‐dependent oxidases, which are a major source

Glutamate release by neurons evokes a pu
Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: Activation by neuropeptide Y
✍ Ortrud Uckermann; Antje Wolf; Franziska Kutzera; Folke Kalisch; Annette G. Beck- 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB

Glial cell swelling is a central cause of ischemic edema in the brain and retina; however, the regulation of glial cell volume by endogenous factors in situ is largely unknown. In slices of the postischemic retina of the rat, the somata of glial (Müller) cells swell upon hypotonic stress that is not

Progressive degeneration of dopamine neu
Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of parkinson's disease does not involve activation of caspase-9 and caspase-3
✍ Allison D. Ebert; Hoo Jae Hann; Martha C. Bohn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

## Abstract 6‐Hydroxydopamine (6‐OHDA), a neurotoxin that causes the death of dopamine (DA) neurons, is commonly used to produce experimental models of Parkinson's disease (PD) in rodents. In the rat model of PD first described by Sauer and Oertel, DA neurons progressively die over several weeks fo